Nikolai Lazarov

Prof. Nikolai Lazarov

Department of Anatomy, Histology and Embryology, MEDICAL UNIVERSITY, Sofia, Sofia-Grad, Bulgaria
+1
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2007 in Brain Research Reviews
Verified
Journal Article
Closed access
Nikolai LazarovNikolai Lazarov
Nikolai Lazarov

11 November 2020 in International journal of legal medicine
Verified
Journal Article
Closed access
PDF file
Diana H. TonevaDiana H. Toneva
Diana H. Toneva
Silviya NikolovaSilviya Nikolova
Silviya Nikolova
Gennady AgreGennady Agre
Gennady Agre
DZDora Zlatareva
Dora Zlatareva
VHVassil Hadjidekov
Vassil Hadjidekov
Nikolai LazarovNikolai Lazarov
Nikolai Lazarov

9 September 2022 in Biology
Verified
Journal Article
Open access
PDF file
Diana H. TonevaDiana H. Toneva
Diana H. Toneva
Silviya NikolovaSilviya Nikolova
Silviya Nikolova
ETElena Tasheva-Terzieva
Elena Tasheva-Terzieva
DZDora Zlatareva
Dora Zlatareva
Nikolai LazarovNikolai Lazarov
Nikolai Lazarov
The level of sexual dimorphism manifested by human bones is an important factor for development of effective sex estimation methods. The aim of the study was to investigate the sexual dimorphism in the size and shape of the viscerocranium using geometric morphometric techniques. It also aimed to explore the sex differences in distinct viscerocranial regions and to establish the most dimorphic region with regard to size and shape. Computed tomography images of 156 males and 184 females were used in the study. Three-dimensional coordinates of 31 landmarks were acquired. Five landmark configurations were constructed from the viscerocranium and its orbital, nasal, maxillary, and zygomatic region. Generalized Procrustes superimposition, principal component analysis, and discriminant analysis were applied to each configuration. The significance of the sex differences in size and shape was assessed and significant differences were found in all configurations. The highest accuracy was obtained from both shape and size of the whole viscerocranium. Based on size only, the highest accuracy was achieved by the nasal region. The accuracy based on shape was generally low for all configurations, but the highest result was attained by the orbital region. Hence, size is a better sex discriminator than shape.

25 October 2007 in Reproductive Biology and Endocrinology
Verified
Journal Article
Open access
PDF file
VRVeronica Rey-Ares
Veronica Rey-Ares
Nikolai LazarovNikolai Lazarov
Nikolai Lazarov
DBDieter Berg
Dieter Berg
UBUlrike Berg
Ulrike Berg
LKLars Kunz
Lars Kunz
Artur MAyerhoferArtur MAyerhofer
Artur MAyerhofer
Background: High levels of dopamine (DA) were described in human ovary and recently evidence for DA receptors in granulosa and luteal cells has been provided, as well. However, neither the full repertoire of ovarian receptors for DA, nor their specific role, is established. Human granulosa cells (GCs) derived from women undergoing in vitro fertilization (IVF) are an adequate model for endocrine cells of the follicle and the corpus luteum and were therefore employed in an attempt to decipher their DA receptor repertoire and functionality. Methods: Cells were obtained from patients undergoing IVF and examined using cDNA-array, RT-PCR, Western blotting and immunocytochemistry. In addition, calcium measurements (with FLUO-4) were employed. Expression of two DA receptors was also examined by in-situ hybridization in rat ovary. Effects of DA on cell viability and cell volume were studied by using an ATP assay and an electronic cell counter system. Results: We found members of the two DA receptor families (D1- and D2 -like) associated with different signaling pathways in human GCs, namely D1 (as expected) and D5 (both are Gs coupled and linked to cAMP increase) and D2, D4 (Gi/Gq coupled and linked to IP3/DAG). D3 was not found. The presence of the trophic hormone hCG (10 IU/ml) in the culture medium for several days did not alter mRNA (semiquantitative RT-PCR) or protein levels (immunocytochemistry/Western blotting) of D1,2,4,5 DA receptors. Expression of prototype receptors for the two families, D1 and D2, was furthermore shown in rat granulosa and luteal cells by in situ hybridization. Among the DA receptors found in human GCs, D2 expression was marked both at mRNA and protein levels and it was therefore further studied. Results of additional RT-PCR and Western blots showed two splice variants (D2L, D2S). Irrespective of these variants, D2 proved to be functional, as DA raised intracellular calcium levels. This calcium mobilizing effect of DA was observed in the absence of extracellular calcium and was abolished by a D2 blocker (L-741,626). DA treatment (48 h) of human GCs resulted in slightly, but significantly enlarged, viable cells. Conclusion: A previous study showed D2 in human GCs, which are linked to cAMP, and the present study reveals the full spectrum of DA receptors present in these endocrine cells, which also includes D2-like receptors, linked to calcium. Ovarian DA can act thus via D1,2,4,5, which are co-expressed by endocrine cells of the follicle and the corpus luteum and are linked to different signaling pathways. This suggests a complex role of DA in the regulation of ovarian processes.

1 October 2014 in Respiratory Physiology & Neurobiology
Verified
Journal Article
Closed access
DADimitrinka Yordanova Atanasova
Dimitrinka Yordanova Atanasova
Nikolai LazarovNikolai Lazarov
Nikolai Lazarov

1 October 1997 in Neuroscience Letters
Verified
Journal Article
Closed access
Nikolai LazarovNikolai Lazarov
Nikolai Lazarov
CPChristof Pilgrim
Christof Pilgrim